One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.
Faricimab by Roche is a strong competitor to Eylea.
Tezepelumab is a powerful new drug for asthma, invented by Amgen and AstraZeneca, with a completely new mechanism of action.
Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.
…that is beating all the competitors to the punch.